<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2023-5536</article-id><article-id custom-type="edn" pub-id-type="custom">GHVZWO</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-5536</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ГЕНЕТИКА В КАРДИОЛОГИИ. ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>VGENETICS IN CARDIOLOGY. LITERATURE REVIEWS</subject></subj-group></article-categories><title-group><article-title>Влияние генетических особенностей пациентов на систолическую и диастолическую функцию после острого инфаркта миокарда (обзор литературы)</article-title><trans-title-group xml:lang="en"><trans-title>Influence of genetic characteristics of patients on systolic and diastolic function after acute myocardial infarction: a literature review</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0320-9312</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Головенкин</surname><given-names>С. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Golovenkin</surname><given-names>S. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Головенкин Сергей Евгеньевич — кандидат медицинских наук, доцент кафедры факультетской терапии</p><p>Красноярск</p></bio><bio xml:lang="en"><p>Sergey E. Golovenkin, associate professor of the Department of faculty therapy</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">gse2008@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6968-7627</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никулина</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikulina</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никулина Светлана Юрьевна — доктор медицинских наук, профессор, заведующий кафедрой факультетской терапии</p><p>Красноярск</p></bio><bio xml:lang="en"><p>Svetlana Yu. Nikulina, professor, head of the Department of faculty therapy</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">nicoulina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2250-5942</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бубнова</surname><given-names>М. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Bubnova</surname><given-names>M. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бубнова Марина Геннадьевна — доктор медицинских наук, профессор, руководитель отдела реабилитации и вторичной профилактики сердечно-сосудистых заболеваний</p><p>Москва</p></bio><bio xml:lang="en"><p>Marina G. Bubnova, professor, head of the Department of rehabilitation and secondary prevention of cardiovascular diseases</p><p>Moscow</p></bio><email xlink:type="simple">mbubnova@gnicpm.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1968-3476</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шульман</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shulman</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шульман Владимир Абрамович — доктор медицинских наук, профессор кафедры факультетской терапии</p><p>Красноярск</p></bio><bio xml:lang="en"><p>Vladimir N. Shulman, professor of the Department of faculty therapy</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">shulman36@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7165-4496</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Максимов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Maksimov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Максимов Владимир Николаевич — доктор медицинских наук, профессор, заведующий лабораторией молекулярно-генетических исследований терапевтических заболеваний</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Vladimir N. Maksimov, professor, head of the laboratory of molecular genetic studies of therapeutic pathology</p><p>Novosibirsk</p></bio><email xlink:type="simple">medik11@mail.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Красноярский государственный медицинский университет им. профессора В.Ф. Войно-Ясенецкого Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V. F. Voino-Yasenetsky Krasnoyarsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>НИИ терапии и профилактической медицины — филиал ФГБНУ ФИЦ Институт цитологии и генетики СО РАН</institution><country>Russian Federation</country></aff><aff xml:lang="en"><institution>Research Institute of Internal and Preventive Medicine – branch of the Federal Research Center Institute of Cytology and Genetics</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>21</day><month>07</month><year>2023</year></pub-date><volume>28</volume><issue>10</issue><fpage>5536</fpage><lpage>5536</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Головенкин С.Е., Никулина С.Ю., Бубнова М.Г., Шульман В.А., Максимов В.Н., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Головенкин С.Е., Никулина С.Ю., Бубнова М.Г., Шульман В.А., Максимов В.Н.</copyright-holder><copyright-holder xml:lang="en">Golovenkin S.E., Nikulina S.Y., Bubnova M.G., Shulman V.N., Maksimov V.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/5536">https://russjcardiol.elpub.ru/jour/article/view/5536</self-uri><abstract><p>Важнейшей задачей при оказании помощи пациентам с инфарктом миокарда является сохранение сократительной способности миокарда. В статье обсуждаются вопросы, касающиеся влияния генетических особенностей пациентов на заживление инфарцированного миокарда, процесс ремоделирования, восстановления систолической и диастолической функции левого желудочка. Одним из подходов к повышению предсказательной способности генетического тестирования является объединение информации о многих вариантах нуклеотидной последовательности в единую систему оценки риска, часто называемую полигенной шкалой риска. В рамках статьи рассмотрены последние публикации, посвященные созданию и использованию полигенных шкал риска. Применение генетических методов при обследовании, дальнейший учет индивидуальных особенностей каждого пациента при выборе терапии и назначении курса реабилитации позволит реализовать индивидуальный подход к каждому больному, что в свою очередь должно позитивно сказаться на прогнозе заболевания.</p><p> </p></abstract><trans-abstract xml:lang="en"><p>The most important task in providing care to patients with myocardial infarction is maintaining myocardial contractility. The article discusses issues related to the influence of genetic characteristics of patients on the repair of infarcted myocardium, the remodeling process, and restoration of left ventricular systolic and diastolic function. One approach to improving the predictive ability of genetic testing is to combine information about many nucleotide sequence variants into a single risk score, often called a polygenic risk score. The article examines recent publications on the creation and use of polygenic risk scores. The use of genetic methods during examination, further consideration of the individual characteristics of each patient when choosing therapy and prescribing a course of rehabilitation will allow for an individual approach to each patient, which in turn should have a positive impact on the disease prognosis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфаркт миокарда</kwd><kwd>генетика</kwd><kwd>систолическая функция левого желудочка</kwd><kwd>диастолическая функция левого желудочка</kwd><kwd>сердечная недостаточность</kwd><kwd>однонуклеотидный полиморфизм</kwd></kwd-group><kwd-group xml:lang="en"><kwd>myocardial infarction</kwd><kwd>genetics</kwd><kwd>left ventricular systolic function</kwd><kwd>left ventricular diastolic function</kwd><kwd>heart failure</kwd><kwd>single nucleotide polymorphism</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование частично поддержано бюджетным проектом НИИТПМ — филиал ИЦиГ СО РАН № 122031700094-5</funding-statement><funding-statement xml:lang="en">The study was partially supported by the budget project of the Research Institute of Internal and Preventive Medicine – branch of the Institute of Cytology and Genetics № 122031700094-5</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шляхто Е.В., Беленков Ю. Н., Бойцов С. А. и др. Проспективное наблюдательное многоцентровое регистровое исследование пациентов с хронической сердечной недостаточностью в Российской Федерации (ПРИОРИТЕТ-ХСН): обоснование, цели и дизайн исследования. Российский кардиологический журнал. 2023;28(6):5456. doi:10.15829/1560-4071-2023-5456. EDN LKSHVP.</mixed-citation><mixed-citation xml:lang="en">Shlyakhto EV, Belenkov YuN, Boytsov SA, et al. Prospective observational multicenter registry study of patients with heart failure in the Russian Federation (PRIORITETCHF): rationale, objectives and design of the study. Russian Journal of Cardiology. 2023;28(6):5456. (In Russ.) doi:10.15829/1560-4071-2023-5456. EDN LKSHVP.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">2021 Рекомендации ESC по диагностике и лечению острой и хронической сердечной недостаточности. Российский кардиологический журнал. 2023;28(1):5168. doi:10.15829/1560-4071-2023-5168. EDN SJMIKK.</mixed-citation><mixed-citation xml:lang="en">McDonagh T, Metra M. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Russian Journal of Cardiology. 2023;28(1):5168. (In Russ.) doi:10.15829/1560-4071-2023-5168. EDN SJMIKK.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4083. doi:10.15829/1560-4071-2020-4083.</mixed-citation><mixed-citation xml:lang="en">Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi:10.15829/1560-4071-2020-4083.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4103. doi:10.15829/1560-4071-2020-4103.</mixed-citation><mixed-citation xml:lang="en">2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction. Russian Journal of Cardiology. 2020;25(11):4103. (In Russ.) doi:10.15829/1560-4071-2020-4103.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Рекомендации ESC по ведению пациентов с острым коронарным синдромом без стойкого подъема сегмента ST 2020. Российский кардиологический журнал. 2021;26(3):4418. doi:10.15829/1560-4071-2021-4418.</mixed-citation><mixed-citation xml:lang="en">2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Russian Journal of Cardiology. 2021;26(3):4418. (In Russ.) doi:10.15829/1560-4071-2021-4418.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы: реабилитация и вторичная профилактика. Российские клинические рекомендации. CardioСоматика. 2014;S1:5-41. doi:10.15829/1560-4071-2015-1-6-52.</mixed-citation><mixed-citation xml:lang="en">Acute myocardial infarction with ST segment elevation electrocardiograms: rehabilitation and secondary prevention. Russian clinical guidelines. CardioSomatica. 2014;S1:5-41. (In Russ.) doi:10.15829/1560-4071-2015-1-6-52.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Затейщиков Д.А., Фаворова О.О., Чумакова О.С. Молекулярная кардиология: от расшифровки генетической природы и механизмов развития заболевания до внедрения в клиническую практику. Терапевтический архив. 2022;94(4):463-6. doi:10.26442/00403660.2022.04.201467.</mixed-citation><mixed-citation xml:lang="en">Zateyshchikov DA, Favorova OO, Chumakova OS. Molecular cardiology: from decoding the genetic nature and mechanisms of the diseases development to the introduction into the clinic. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(4):463-6. (In Russ.) doi:10.26442/00403660.2022.04.201467.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Мешков А.Н., Киселева А.В., Ершова А.И. и др. Варианты генов ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL и риск ишемической болезни сердца. Российский кардиологический журнал. 2022;27(10):5232. doi:10.15829/1560-4071-2022-5232. EDN FAKGMM.</mixed-citation><mixed-citation xml:lang="en">Meshkov AN, Kiseleva AV, Ershova AI, et al. ANGPTL3, ANGPTL4, APOA5, APOB, APOC2, APOC3, LDLR, PCSK9, LPL gene variants and coronary artery disease risk. Russian Journal of Cardiology. 2022;27(10):5232. (In Russ.) doi:10.15829/1560-4071-2022-5232. EDN FAKGMM.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Налесник Е. О., Муслимова Э.Ф., Афанасьев С.А. и др. Ассоциация полиморфизмов гена ACE с сердечно-сосудистыми осложнениями у пациентов, перенесших плановые чрескожные коронарные вмешательства. Российский кардиологический журнал. 2022;27(10):4968. doi:10.15829/1560-4071-2022-4968. EDN DJEULB.</mixed-citation><mixed-citation xml:lang="en">Nalesnik EO, Muslimova EF, Afanasiev SA, et al. Association of ACE gene polymorphisms with cardiovascular events in patients after elective percutaneous coronary interventions. Russian Journal of Cardiology. 2022;27(10):4968. (In Russ.) doi:10.15829/1560-4071-2022-4968. EDN DJEULB.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Яхонтов Д.А., Останина Ю.О., Конончук В.В. и др. Уровень микроРНК у больных стабильной ишемической болезнью сердца с пограничными стенозами коронарных артерий. Российский кардиологический журнал. 2022;27(10):5224. doi:10.15829/1560-4071-2022-5224. EDN EDDUTU.</mixed-citation><mixed-citation xml:lang="en">Yakhontov DA, Ostanina YuO, Kononchuk VV, et al. MicroRNA level in patients with stable coronary artery disease with borderline coronary artery stenosis. Russian Journal of Cardiology. 2022;27(10):5224. (In Russ.) doi:10.15829/1560-4071-2022-5224. EDN EDDUTU.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ложкина Н. Г., Толмачева А.А., Хасанова М. Х. и др. Генетические предикторы пятилетних исходов перенесенного острого коронарного синдрома. Российский кардиологический журнал. 2019;(10):86-90. doi:10.15829/1560-4071- 2019-10-86-90.</mixed-citation><mixed-citation xml:lang="en">Lozhkina NG, Tolmacheva AA, Khasanova MX, et al. Genetic predictors of five-year outcomes of acute coronary syndrome. Russian Journal of Cardiology. 2019;(10):86- 90. (In Russ.) doi:10.15829/1560-4071-2019-10-86-90.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Понасенко А.В., Цепокина А.В., Хуторная М.В. и др. Концентрация интерлейкина-18 у пациентов со стабильной формой ишемической болезни сердца ассоциирована с полиморфизмом генов IL18RAP и IL18R1 и риском развития инфаркта миокарда. Российский кардиологический журнал. 2020;25(10):3977. doi:10.15829/1560-4071-2020-3977.</mixed-citation><mixed-citation xml:lang="en">Ponasenko AV, Tsepokina AV, Khutornaya MV, et al. Interleukin 18 levels in patients with stable coronary artery disease is associated with IL18RAP and IL18R1 gene polymorphism and the risk of myocardial infarction. Russian Journal of Cardiology. 2020;25(10):3977. (In Russ.) doi:10.15829/1560-4071-2020-3977.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Вахрушев Ю.А., Куулар А.А., Лебедева В.К. и др. Варианты гена RBM20, ассоциированные с дилатацией левого предсердия у пациентов с постинфарктным кардиосклерозом и сердечной недостаточностью с низкой фракцией выброса. Российский кардиологический журнал. 2021;26(10):4707. doi:10.15829/1560-4071-2021-4707.</mixed-citation><mixed-citation xml:lang="en">Vakhrushev YuA, Kuular AA, Lebedeva VK, et al. RBM20 gene variants associated with left atrial dilatation in patients with old myocardial infarction and heart failure with reduced ejection fraction. Russian Journal of Cardiology. 2021;26(10):4707. (In Russ.) doi:10.15829/1560-4071-2021-4707.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Печерина Т.Б., Кутихин А.Г. Биомаркеры фиброза миокарда и их генетическое регулирование у пациентов с сердечной недостаточностью. Российский кардиологический журнал. 2020;25(10):3933. doi:10.15829/1560-4071-2020-3933.</mixed-citation><mixed-citation xml:lang="en">Pecherina TB, Kutikhin AG. Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure. Russian Journal of Cardiology. 2020;25(10):3933. (In Russ.) doi:10.15829/1560-4071-2020-3933.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Park S, Nguyen NB, Pezhouman A, et al. Cardiac fibrosis: potential therapeutic targets. Transl Res. 2019;209:121-37. doi:10.1016/j.trsl.2019.03.001.</mixed-citation><mixed-citation xml:lang="en">Park S, Nguyen NB, Pezhouman A, et al. Cardiac fibrosis: potential therapeutic targets. Transl Res. 2019;209:121-37. doi:10.1016/j.trsl.2019.03.001.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Fan Z, Guan J.Antifibrotic therapies to control cardiac fibrosis. Biomater Res. 2016;20:13. doi:10.1186/s40824-016-0060-8.</mixed-citation><mixed-citation xml:lang="en">Fan Z, Guan J.Antifibrotic therapies to control cardiac fibrosis. Biomater Res. 2016;20:13. doi:10.1186/s40824-016-0060-8.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Бражник В.А., Минушкина Л.О., Аверкова А.О. и др. Полиморфизм гена TNF у больных с острым коронарным синдромом: данные регистров ОРАКУЛ I и ОРАКУЛ II. Российский кардиологический журнал. 2018;(10):22-7. doi:10.15829/1560-4071-2018-10-22-27.</mixed-citation><mixed-citation xml:lang="en">Brazhnik VА, Minushkina LO, Averkova АО, et al. Polymorphism of TNF gene in acute coronary syndrome patients: data from the registries ORACLE I and ORACLE II. Russian Journal of Cardiology. 2018;(10):22-7. (In Russ.) doi:10.15829/1560-4071-2018-10-22-27.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Минушкина Л.О., Бражник В.А., Селезнева Н.Д. и др. Ассоциация полиморфизма гена фактора некроза опухоли с гипертрофией миокарда левого желудочка у больных с артериальной гипертензией и ИБС. Кремлевская медицина. Клинический вестник. 2019;1:69-74. doi:10.26269/d6gp-4t10.</mixed-citation><mixed-citation xml:lang="en">Minushkina LO, Brazhnik VA, Selezneva ND, et al. Left ventricular hypertrophy of arterial hypertension in patients with CHD is associated with polymorphism of the tumor necrosis factor gene. Kremlin Medicine. Clinical Bulletin. 2019;1:69-74. (In Russ.) doi:10.26269/d6gp-4t10.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Лясникова Е.А., Улитин А.М., Тишкова В.М. Генетические детерминанты, ассоциированные с развитием и прогнозом постинфарктного ремоделирования и хронической сердечной недостаточности. Трансляционная медицина. 2018;5(1):15-24. doi:10.15829/1560-51812-2018-58.</mixed-citation><mixed-citation xml:lang="en">Lyasnikova EA, Ulitin AM, Tishkova VM. Genetic determinants associated with the development and prognosis of post-infarction remodeling and chronical heart failure. Translational Medicine. 2018;5(1):15-24. (In Russ.) doi:10.15829/1560-51812-2018-58.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Гриценко О.В., Чумакова Г.А., Груздева О.В. и др. Профибротические генетические полиморфизмы как возможные факторы риска развития диастолической дисфункции у больных с эпикардиальным ожирением. Российский кардиологический журнал. 2022;27(10):5208. doi:10.15829/1560-4071-2022-5208. EDN EYNYCA.</mixed-citation><mixed-citation xml:lang="en">Gritsenko OV, Chumakova GA, Gruzdeva OV, et al. Profibrotic genetic polymorphisms as possible risk factors for the development of diastolic dysfunction in patients with epicardial adiposity. Russian Journal of Cardiology. 2022;27(10):5208. (In Russ.) doi:10.15829/1560-4071-2022-5208. EDN EYNYCA.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Feng AF, Liu ZH, Zhou SL, et al. Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a metaanalysis. BMC Cardiovasc Disord. 2017 Jul 3;17(1):174. doi:10.1186/s12872-017-0608-0. PMID: 28673246; PMCID: PMC5496365.</mixed-citation><mixed-citation xml:lang="en">Feng AF, Liu ZH, Zhou SL, et al. Effects of AMPD1 gene C34T polymorphism on cardiac index, blood pressure and prognosis in patients with cardiovascular diseases: a metaanalysis. BMC Cardiovasc Disord. 2017 Jul 3;17(1):174. doi:10.1186/s12872-017-0608-0. PMID: 28673246; PMCID: PMC5496365.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hung CL, Chang SC, Chang SH, et al.; MAGNET Study Investigator. Genetic Polymorphisms of Alcohol Metabolizing Enzymes and Alcohol Consumption are Associated With Asymptomatic Cardiac Remodeling and Subclinical Systolic Dysfunction in Large Community-Dwelling Asians. Alcohol Alcohol. 2017;52(6):638-46. doi:10.1093/alcalc/agx049.</mixed-citation><mixed-citation xml:lang="en">Hung CL, Chang SC, Chang SH, et al.; MAGNET Study Investigator. Genetic Polymorphisms of Alcohol Metabolizing Enzymes and Alcohol Consumption are Associated With Asymptomatic Cardiac Remodeling and Subclinical Systolic Dysfunction in Large Community-Dwelling Asians. Alcohol Alcohol. 2017;52(6):638-46. doi:10.1093/alcalc/agx049.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Strutynskyi RB, Voronkov LG, Nagibin VS, et al. Changes of the echocardiographic parameters in chronic heart failure patients with Ile337val, Glu23lys, and Ser1369ala polymorphisms of genes encoding the ATP-sensitive potassium channels subunits in the Ukrainian population. Ann Hum Genet. 2018;82(5):272-9. doi:10.1111/ahg.12250.</mixed-citation><mixed-citation xml:lang="en">Strutynskyi RB, Voronkov LG, Nagibin VS, et al. Changes of the echocardiographic parameters in chronic heart failure patients with Ile337val, Glu23lys, and Ser1369ala polymorphisms of genes encoding the ATP-sensitive potassium channels subunits in the Ukrainian population. Ann Hum Genet. 2018;82(5):272-9. doi:10.1111/ahg.12250.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Andersson C, Lin H, Liu C, et al. Integrated Multiomics Approach to Identify Genetic Underpinnings of Heart Failure and Its Echocardiographic Precursors: Framingham Heart Study. Circ Genom Precis Med. 2019;12(12):e002489. doi:10.1161/CIRCGEN.118.002489. Epub 2019 Nov 8. PMID: 31703168.</mixed-citation><mixed-citation xml:lang="en">Andersson C, Lin H, Liu C, et al. Integrated Multiomics Approach to Identify Genetic Underpinnings of Heart Failure and Its Echocardiographic Precursors: Framingham Heart Study. Circ Genom Precis Med. 2019;12(12):e002489. doi:10.1161/CIRCGEN.118.002489. Epub 2019 Nov 8. PMID: 31703168.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Naman T, Abuduhalike R, Abudouwayiti A, et al. Development and validation of a novel nomogram to predict the impact of the polymorphism of the ICAM-1 gene on the prognosis of ischemic cardiomyopathy. Clin Genet. 2023;104(3):313-23. doi:10.1111/cge.14385.</mixed-citation><mixed-citation xml:lang="en">Naman T, Abuduhalike R, Abudouwayiti A, et al. Development and validation of a novel nomogram to predict the impact of the polymorphism of the ICAM-1 gene on the prognosis of ischemic cardiomyopathy. Clin Genet. 2023;104(3):313-23. doi:10.1111/cge.14385.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ramalingam S, Radhakrishnan S, Kaliappan T, et al. The genetics of cardiac failure: Role of a G protein-coupled receptor polymorphism in therapeutic response in an Indian population. J Clin Transl Res. 2021;7(4):501-10.</mixed-citation><mixed-citation xml:lang="en">Ramalingam S, Radhakrishnan S, Kaliappan T, et al. The genetics of cardiac failure: Role of a G protein-coupled receptor polymorphism in therapeutic response in an Indian population. J Clin Transl Res. 2021;7(4):501-10.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Ye L, Su L, Wang C, et al. Truncations of the titin Z-disc predispose to a heart failure with preserved ejection phenotype in the context of pressure overload. PLoS One. 2018;13(7):e0201498. doi:10.1371/journal.pone.0201498.</mixed-citation><mixed-citation xml:lang="en">Ye L, Su L, Wang C, et al. Truncations of the titin Z-disc predispose to a heart failure with preserved ejection phenotype in the context of pressure overload. PLoS One. 2018;13(7):e0201498. doi:10.1371/journal.pone.0201498.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Levin MG, Tsao NL, Singhal P, et al.; Regeneron Genetics Center. Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat Commun. 2022;13(1):6914. doi:10.1038/s41467-022-34216-6.</mixed-citation><mixed-citation xml:lang="en">Levin MG, Tsao NL, Singhal P, et al.; Regeneron Genetics Center. Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat Commun. 2022;13(1):6914. doi:10.1038/s41467-022-34216-6.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Choi SW, Mak TSH, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15(9):2759-72. doi:10.1038/s41596-020-0353-1.</mixed-citation><mixed-citation xml:lang="en">Choi SW, Mak TSH, O’Reilly PF. Tutorial: a guide to performing polygenic risk score analyses. Nat Protoc. 2020;15(9):2759-72. doi:10.1038/s41596-020-0353-1.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Banerjee A, Dashtban A, Chen S, et al. Identifying subtypes of heart failure from three electronic health record sources with machine learning: an external, prognostic, and genetic validation study. Lancet Digit Health. 2023;5(6):e370-e379. doi:10.1016/S2589-7500(23)00065-1.</mixed-citation><mixed-citation xml:lang="en">Banerjee A, Dashtban A, Chen S, et al. Identifying subtypes of heart failure from three electronic health record sources with machine learning: an external, prognostic, and genetic validation study. Lancet Digit Health. 2023;5(6):e370-e379. doi:10.1016/S2589-7500(23)00065-1.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Lee DSM, DePaolo JS, Aragam KG, et al. Common- and rare-variant genetic architecture of heart failure across the allele frequency spectrum. medRxiv [Preprint]. 2023:2023.07.16.23292724. doi:10.1101/2023.07.16.23292724.</mixed-citation><mixed-citation xml:lang="en">Lee DSM, DePaolo JS, Aragam KG, et al. Common- and rare-variant genetic architecture of heart failure across the allele frequency spectrum. medRxiv [Preprint]. 2023:2023.07.16.23292724. doi:10.1101/2023.07.16.23292724.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Han Y, Lu J, Chen B, et al. A novel polygenic risk score improves prognostic prediction of heart failure with preserved ejection fraction in the Chinese Han population. Eur J Prev Cardiol. 2023:zwad209. doi:10.1093/eurjpc/zwad209. Epub ahead of print.</mixed-citation><mixed-citation xml:lang="en">Han Y, Lu J, Chen B, et al. A novel polygenic risk score improves prognostic prediction of heart failure with preserved ejection fraction in the Chinese Han population. Eur J Prev Cardiol. 2023:zwad209. doi:10.1093/eurjpc/zwad209. Epub ahead of print.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Tsao NL, Judy R, Levin MG, et al. Evaluation of the Performance of the RECODe Equation with the Addition of Polygenic Risk Scores for Adverse Cardiovascular Outcomes in Individuals with Type II Diabetes. medRxiv [Preprint]. 2023:2023.05.03.23289457. doi:10.1101/2023.05.03.23289457.</mixed-citation><mixed-citation xml:lang="en">Tsao NL, Judy R, Levin MG, et al. Evaluation of the Performance of the RECODe Equation with the Addition of Polygenic Risk Scores for Adverse Cardiovascular Outcomes in Individuals with Type II Diabetes. medRxiv [Preprint]. 2023:2023.05.03.23289457. doi:10.1101/2023.05.03.23289457.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Luo J, Noordam R, Jukema JW, et al. Low leukocyte mitochondrial DNA abundance drives atherosclerotic cardiovascular diseases: a cohort and Mendelian randomization study. Cardiovasc Res. 2023;119(4):998-1007. doi:10.1093/cvr/cvac182.</mixed-citation><mixed-citation xml:lang="en">Luo J, Noordam R, Jukema JW, et al. Low leukocyte mitochondrial DNA abundance drives atherosclerotic cardiovascular diseases: a cohort and Mendelian randomization study. Cardiovasc Res. 2023;119(4):998-1007. doi:10.1093/cvr/cvac182.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng H, Huang S, Wei G, et al. CircRNA Samd4 induces cardiac repair after myocardial infarction by blocking mitochondria-derived ROS output. Mol Ther. 2022;30(11):3477-98. doi:10.1016/j.ymthe.2022.06.016.</mixed-citation><mixed-citation xml:lang="en">Zheng H, Huang S, Wei G, et al. CircRNA Samd4 induces cardiac repair after myocardial infarction by blocking mitochondria-derived ROS output. Mol Ther. 2022;30(11):3477-98. doi:10.1016/j.ymthe.2022.06.016.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kuo CL, Pilling LC, Kuchel GA, et al. Telomere length and aging‐related outcomes in humans: A Mendelian randomization study in 261,000 older participants. Aging Cell. 2019;18(6):e13017.</mixed-citation><mixed-citation xml:lang="en">Kuo CL, Pilling LC, Kuchel GA, et al. Telomere length and aging‐related outcomes in humans: A Mendelian randomization study in 261,000 older participants. Aging Cell. 2019;18(6):e13017.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Romaine SPR, Denniff M, Codd V, et al. Telomere length is independently associated with all-cause mortality in chronic heart failure. Heart. 2022;108(2):124-9. doi:10.1136/heartjnl-2020-318654.</mixed-citation><mixed-citation xml:lang="en">Romaine SPR, Denniff M, Codd V, et al. Telomere length is independently associated with all-cause mortality in chronic heart failure. Heart. 2022;108(2):124-9. doi:10.1136/heartjnl-2020-318654.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Gorący I, Gorący A, Kaczmarczyk M, et al. The Genetic Variants in the Renin-Angiotensin System and the Risk of Heart Failure in Polish Patients. Genes (Basel). 2022;13(7):1257. doi:10.3390/genes13071257.</mixed-citation><mixed-citation xml:lang="en">Gorący I, Gorący A, Kaczmarczyk M, et al. The Genetic Variants in the Renin-Angiotensin System and the Risk of Heart Failure in Polish Patients. Genes (Basel). 2022;13(7):1257. doi:10.3390/genes13071257.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Yu C, Zhou W.Peripheral neutrophils and naive CD4 T cells predict the development of heart failure following acute myocardial infarction: A bioinformatic study. Rev Port Cardiol (Engl Ed). 2021;40(11):839-47. doi:10.1016/j.repce.2021.11.002.</mixed-citation><mixed-citation xml:lang="en">Yu C, Zhou W.Peripheral neutrophils and naive CD4 T cells predict the development of heart failure following acute myocardial infarction: A bioinformatic study. Rev Port Cardiol (Engl Ed). 2021;40(11):839-47. doi:10.1016/j.repce.2021.11.002.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Douvaras P, Antonatos DG, Kekou K, et al. Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction. Cardiology. 2009;114(1):11-8. doi:10.1159/000210189.</mixed-citation><mixed-citation xml:lang="en">Douvaras P, Antonatos DG, Kekou K, et al. Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction. Cardiology. 2009;114(1):11-8. doi:10.1159/000210189.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Sun D, Zhu Z, Zhang Y, et al. Relation of genetic polymorphisms in microRNAs with diastolic and systolic function in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2022;32(12):2877-82. doi:10.1016/j.numecd.2022.09.002.</mixed-citation><mixed-citation xml:lang="en">Sun D, Zhu Z, Zhang Y, et al. Relation of genetic polymorphisms in microRNAs with diastolic and systolic function in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2022;32(12):2877-82. doi:10.1016/j.numecd.2022.09.002.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Duarte VHR, Cruz MS, Bertolami A, et al. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Sci Rep. 2022;12(1):18612. doi:10.1038/s41598-022-22040-3.</mixed-citation><mixed-citation xml:lang="en">Duarte VHR, Cruz MS, Bertolami A, et al. TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis. Sci Rep. 2022;12(1):18612. doi:10.1038/s41598-022-22040-3.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Türkmen D, Masoli JAH, Delgado J, et al. Calcium-channel blockers: Clinical outcome associations with reported pharmacogenetics variants in 32000 patients. Br J Clin Pharmacol. 2023;89(2):853-64. doi:10.1111/bcp.15541.</mixed-citation><mixed-citation xml:lang="en">Türkmen D, Masoli JAH, Delgado J, et al. Calcium-channel blockers: Clinical outcome associations with reported pharmacogenetics variants in 32000 patients. Br J Clin Pharmacol. 2023;89(2):853-64. doi:10.1111/bcp.15541.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Luo HY, Gao LC, Long HZ, et al. Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure. Eur J Clin Pharmacol. 2023;79(5):663-70. doi:10.1007/s00228-023-03484-6.</mixed-citation><mixed-citation xml:lang="en">Luo HY, Gao LC, Long HZ, et al. Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure. Eur J Clin Pharmacol. 2023;79(5):663-70. doi:10.1007/s00228-023-03484-6.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Dubé MP, Chazara O, Lemaçon A, et al. Pharmacogenomic study of heart failure and candesartan response from the CHARM programme. ESC Heart Fail. 2022;9(5):2997- 3008. doi:10.1002/ehf2.14026.</mixed-citation><mixed-citation xml:lang="en">Dubé MP, Chazara O, Lemaçon A, et al. Pharmacogenomic study of heart failure and candesartan response from the CHARM programme. ESC Heart Fail. 2022;9(5):2997- 3008. doi:10.1002/ehf2.14026.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Lian J, Shi X, Jia X, et al. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study. J Hypertens. 2023;41(1):44-50. doi:10.1097/HJH.0000000000003297.</mixed-citation><mixed-citation xml:lang="en">Lian J, Shi X, Jia X, et al. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study. J Hypertens. 2023;41(1):44-50. doi:10.1097/HJH.0000000000003297.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Huber M, Lezius S, Reibis R, et al. A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy. Int J Mol Sci. 2015;16(8):17456-68. doi:10.3390/ijms160817456.</mixed-citation><mixed-citation xml:lang="en">Huber M, Lezius S, Reibis R, et al. A Single Nucleotide Polymorphism near the CYP17A1 Gene Is Associated with Left Ventricular Mass in Hypertensive Patients under Pharmacotherapy. Int J Mol Sci. 2015;16(8):17456-68. doi:10.3390/ijms160817456.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Cronjé HT, Karhunen V, Hovingh GK, et al. Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study. BMC Med. 2023;21(1):158. doi:10.1186/s12916-023-02867-x.</mixed-citation><mixed-citation xml:lang="en">Cronjé HT, Karhunen V, Hovingh GK, et al. Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study. BMC Med. 2023;21(1):158. doi:10.1186/s12916-023-02867-x.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Djordjevic A, Zivkovic M, Boskovic M, et al. Variants Tagging LGALS-3 Haplotype Block in Association with First Myocardial Infarction and Plasma Galectin-3 Six Months after the Acute Event. Genes (Basel). 2022;14(1):109. doi:10.3390/genes14010109.</mixed-citation><mixed-citation xml:lang="en">Djordjevic A, Zivkovic M, Boskovic M, et al. Variants Tagging LGALS-3 Haplotype Block in Association with First Myocardial Infarction and Plasma Galectin-3 Six Months after the Acute Event. Genes (Basel). 2022;14(1):109. doi:10.3390/genes14010109.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Qiao P, Xu J, Liu X, Li X.Tanshinone IIA Improves Ventricular Remodeling following Cardiac Infarction by Regulating miR-205-3p. Dis Markers. 2021;2021:8740831. doi:10.1155/2021/8740831.</mixed-citation><mixed-citation xml:lang="en">Qiao P, Xu J, Liu X, Li X.Tanshinone IIA Improves Ventricular Remodeling following Cardiac Infarction by Regulating miR-205-3p. Dis Markers. 2021;2021:8740831. doi:10.1155/2021/8740831.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Ji JJ, Qian LL, Zhu Y, et al. Kallistatin/Serpina3c inhibits cardiac fibrosis after myocardial infarction by regulating glycolysis via Nr4a1 activation. Biochim Biophys Acta Mol Basis Dis. 2022;1868(9):166441. doi:10.1016/j.bbadis.2022.166441.</mixed-citation><mixed-citation xml:lang="en">Ji JJ, Qian LL, Zhu Y, et al. Kallistatin/Serpina3c inhibits cardiac fibrosis after myocardial infarction by regulating glycolysis via Nr4a1 activation. Biochim Biophys Acta Mol Basis Dis. 2022;1868(9):166441. doi:10.1016/j.bbadis.2022.166441.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, Jia Y, Xu Q, et al. Association between myeloperoxidase and the risks of ischemic stroke, heart failure, and atrial fibrillation: A Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2023;33(1):210-8. doi:10.1016/j.numecd.2022.09.027.</mixed-citation><mixed-citation xml:lang="en">Wang Y, Jia Y, Xu Q, et al. Association between myeloperoxidase and the risks of ischemic stroke, heart failure, and atrial fibrillation: A Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2023;33(1):210-8. doi:10.1016/j.numecd.2022.09.027.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Hoffman M, Palioura D, Kyriazis ID, et al. Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy. Circulation. 2021;143(11):1139-56. doi:10.1161/CIRCULATIONAHA.120.047420.</mixed-citation><mixed-citation xml:lang="en">Hoffman M, Palioura D, Kyriazis ID, et al. Cardiomyocyte Krüppel-Like Factor 5 Promotes De Novo Ceramide Biosynthesis and Contributes to Eccentric Remodeling in Ischemic Cardiomyopathy. Circulation. 2021;143(11):1139-56. doi:10.1161/CIRCULATIONAHA.120.047420.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
